
- /
- Supported exchanges
- / US
- / SDPNF.OTCGREY
Sime Darby Plantation Berhad (SDPNF OTCGREY) stock market data APIs
Sime Darby Plantation Berhad Financial Data Overview
SD Guthrie Berhad operates as an integrated plantations company in Malaysia and internationally. It is involved in the development, cultivation, and management of oil palm, rubber, coconut, and sugarcane plantation estates; milling of fresh fruit bunches into crude palm oil and palm kernel; cattle rearing and beef production; and crushing of palm kernel to crude palm kernel oil and palm kernel expeller. In addition, it offers refined oils and fats, and oil palm seeds and seedlings; sells crude palm oil, oleochemical products; refines coconut oils; biodiesel products; sells derivatives; and develops green technology and renewable energy, including solar, biogas and biomass projects. Further, the company engages in the trade of agricultural products and services; research and breeding programmes of oil palm; supply of local manpower and related services; manufacture and marketing of rat baits; trade of agricultural related products; and agricultural mechanization and commercialization of prototype machines and equipment, as well as provision research and development services in biotechnology and agriculture. Additionally, it provides oil palm tissue culture and technical product support services; red palm oils and tocotrienol based, vegetables oil, and fat products; processes edible oil; distributes and markets cooking oil, coconut oil, and palm related products; and acts as a sub-marketing agent. It also operates and manages childcare centre, rest/guest house, cafeterias/canteens, golf course, and tourist attraction places; rents conventional and recreational facilities; acquires, develops, and invests in trademarks, patents and intellectual property rights; holds land; provides advisory and management consultancy services; acquires, processes, produces, and sells ingredients for food, feed, nuritional, pharmaceutical, and cosmetical industry. The company was incorporated in 2004 and is based in Petaling Jaya, Malaysia.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Sime Darby Plantation Berhad data using free add-ons & libraries
Get Sime Darby Plantation Berhad Fundamental Data
Sime Darby Plantation Berhad Fundamental data includes:
- Net Revenue: 20 510 M
- EBITDA: 4 580 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-02-16
- EPS/Forecast: 0.09
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sime Darby Plantation Berhad News

Are Robust Financials Driving The Recent Rally In SD Guthrie Berhad's (KLSE:SDG) Stock?
SD Guthrie Berhad's (KLSE:SDG) stock is up by a considerable 13% over the past three months. Since the market usually pay for a company’s long-term fundamentals, we decided to study the company’s ...


SD Guthrie Berhad Second Quarter 2025 Earnings: EPS: RM0.073 (vs RM0.06 in 2Q 2024)
SD Guthrie Berhad (KLSE:SDG) Second Quarter 2025 Results Key Financial Results Revenue: RM5.17b (up 4.1% from 2Q 2024). Net income: RM505.0m (up 22% from 2Q 2024). Profit margin: 9.8% (up from 8.4% ...

The Return Trends At SD Guthrie Berhad (KLSE:SDG) Look Promising
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. One common approach is to try and find a company with returns on ca...

Coeptis Pharmaceuticals Enters into Exclusive Option Agreements with VyGen-Bio to Co-develop Technologies Designed to Improve the Treatment of CD38-Related Cancers
Technologies being developed from VyGen-Bio's Gene-Edited Antibody Resistant NK (GEAR-NK) Platform WEXFORD, Pa., May 18, 2021 /PRNewswire/ -- Coeptis Pharmaceuticals, Inc., a wholly-owned subsidiary ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.